https://orcid.org/0000-0002-1644-5544
References
- Li Z, Li T, Tang J, et al. Antibacterial activity of surfactin and synergistic effect with conventional antibiotics against methicillin-resistant staphylococcus aureus isolated from patients with diabetic foot Ulcers. Diab Metab Synd Obes. 2023;16:3727–3737. doi:10.2147/DMSO.S435062
- Wardoyo S, Anwar T. Antibacterial activity of surfactin and synergistic effect with conventional antibiotics against methicillin-resistant staphylococcus aureus isolated from patients with diabetic foot ulcers. Diab Metab Synd Obes. 2023;16:3995–3996. doi:10.2147/DMSO.S452011
- Zhu Y, Hao W, Wang X, et al. Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug‐resistant infections. Med Res Rev. 2022;42(4):1377–1422. doi:10.1002/med.21879
- Otvos L, Ostorhazi E. Therapeutic utility of antibacterial peptides in wound healing. Exp Rev Anti-Infective Ther. 2015;13(7):871–881. doi:10.1586/14787210.2015.1033402
- Lipsky Benjamin A, Holroyd Kenneth J, Zasloff M. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double‐blinded, multicenter trial of pexiganan cream. Clinl Infect Dis. 2008;47(12):1537–1545. doi:10.1086/593185
- Magana M, Pushpanathan M, Santos AL, et al. The value of antimicrobial peptides in the age of resistance. Lancet Infect Dis. 2020;20(9):e216–e230. doi:10.1016/S1473-3099(20)30327-3